MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/15/1043/001 
Nucala 
100 mg 
EU/1/15/1043/002 
Nucala 
100 mg 
EU/1/15/1043/003 
Nucala   
100 mg 
EU/1/15/1043/004 
Nucala   
100 mg 
EU/1/15/1043/005 
Nucala   
100 mg 
EU/1/15/1043/006 
Nucala   
100 mg 
Powder for 
solution for 
injection 
Powder for 
solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Subcutaneous 
use 
Subcutaneous 
use 
Subcutaneous 
use 
Subcutaneous 
use 
Subcutaneous 
use 
Subcutaneous 
use 
EU/1/15/1043/007 
Nucala   
100 mg 
Solution for 
injection 
Subcutaneous 
use 
vial (glass) 
100 mg 
1 vial 
vial (glass) 
100 mg 
3 (3 x 1) vials 
(multipack) 
Pre-filled syringe 
(glass) in pre-filled 
pen 
Pre-filled syringe 
(glass) in pre-filled 
pen 
Pre-filled syringe 
(glass) 
Pre-filled syringe 
(glass) 
Pre-filled syringe 
(glass) in pre-filled 
pen 
1 ml (100 mg/ml)  1 pre-filled pen  
1 ml (100 mg/ml)  3 (3 x 1) pre-
filled pens 
(multipack)  
1 ml (100 mg/ml)  1 pre-filled 
syringe  
1 ml (100 mg/ml)  3 (3 x 1) pre-
filled syringes 
(multipack)  
1 ml (100 mg/ml)  9 (9 x 1) pre-
filled pens 
(multipack)  
1 ml (100 mg/ml)  9 (9 x 1) pre-
filled syringes 
(multipack)  
EU/1/15/1043/008 
Nucala   
100 mg 
Solution for 
injection 
Subcutaneous 
use 
Pre-filled syringe 
(glass) 
EU/1/15/1043/009 
Nucala 
40 mg 
EU/1/15/1043/010 
Nucala 
40 mg 
Solution for 
injection 
Solution for 
injection 
Subcutaneous 
use 
Pre-filled syringe 
(glass) 
0.4 ml 
(40 mg/0.4 ml) 
1 pre-filled 
syringe 
Subcutaneous 
use 
Pre-filled syringe 
(glass) 
0.4 ml 
(40 mg/0.4 ml) 
3 (3 x 1) pre-
filled syringes 
(multipack) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
